| Terbinafine hydrochloride nanovesicular gel: In vitro characterization, ex vivo permeation and clinical investigation SM AbdelSamie, AO Kamel, OA Sammour, SM Ibrahim European Journal of Pharmaceutical Sciences 88, 91-100, 2016 | 39 | 2016 |
| Food to medicine transformation of stilbenoid vesicular and lipid-based nanocarriers: technological advances SMA Samie, M Nasr Drug Delivery Aspects, 227-245, 2020 | 21 | 2020 |
| A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic … SMA Mohamed, A Wohlmann, P Schofield, KCS Sia, H McCalmont, ... International Journal of Biological Macromolecules 190, 214-223, 2021 | 4 | 2021 |
| TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells P Truong, S Shen, S Joshi, MI Islam, L Zhong, MJ Raftery, A Afrasiabi, ... Nature Communications 15 (1), 7360, 2024 | 2 | 2024 |
| An antibody fragment-decorated liposomal conjugate targets Philadelphia-like acute lymphoblastic leukemia SMA Mohamed, P Schofield, H McCalmont, E Moles, KH Friedrich, ... International Journal of Biological Macromolecules 254, 127596, 2024 | 2 | 2024 |
| Genome-Wide CRISPR-Cas9 Screening Identifies a Synergy between Hypomethylating Agents and SUMOylation Blockade in MDS/AML P Truong, S Shen, S Joshi, MI Islam, L Zhong, M Raftery, A Afrasiabi, ... bioRxiv, 2024.04. 17.589858, 2024 | 1 | 2024 |
| Abstract B134: Targeting Philadelphia chromosome-like acute lymphoblastic leukemia with a novel CRLF2 antibody fragment-drug conjugate RB Lock, SMA Mohamed, P Schofield, KH Friedrich, D Christ, ... Molecular Cancer Therapeutics 22 (12_Supplement), B134-B134, 2023 | | 2023 |
| A Novel Engineered Single-Chain Antibody Fragment for Targeting Pediatric Philadelphia Chromosome-like Acute Lymphoblastic Leukemia SMA Mohamed, K Sia, KH Friedrich, A Wohlmann, S Savvides, ... Blood 136, 36, 2020 | | 2020 |
Daniel ChristProfessor Garvan Institute of Medical Research在 garvan.org.au 的电子邮件经过验证
